Cetera Investment Advisers Hepion Pharmaceuticals, Inc. Transaction History

Cetera Investment Advisers

  • $42.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.31 - $1.06 $3,095 - $10,585
-9,986 Reduced 33.59%
19,746 $15,000
Q4 2022

Feb 14, 2023
BUY
$0.27 - $11.9 $4,983 - $219,662
18,459 Added 163.75%
29,732 $8,000
Q3 2022

Nov 10, 2022
BUY
$0.51 - $10.4 $5,749 - $117,239
11,273 New
11,273 $6,000

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $45.7M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email